Drug Discovery 2026 returns to ExCeL London from 14–15 October to celebrate 20 years of collaboration and inclusion. Keynote programme includes presentation from Dr Sam Barrell CBE and panel discussion with Dr Anne Phelan, Dr Jason Mellad, Prof Sir Mene Pangalos and Prof Raghib Ali OBE
In this blog, Ethan Almond reflects on the inaugral BioSolutions UK conference, which brought together over 200 innovators, policymakers and industry leaders alongside an additional 29 investors.
The UK BioIndustry Association (BIA) is the UK’s trade association for innovative life sciences and the leading UK-wide forum for expert communities and high quality peer-to-peer networking in the sector.
In this guest blog, Dan Stanton, Trade Media Expert at Sartorius Bioprocess Solutions, discusses how tight funding, manual tech transfer and product specific analytics are keeping cell and gene therapies (CGTs) from realising their potential.
In this guest blog, Rubin Joshi, Business Development Manager at Aldevron, explains how scaling adeno-associated virus (AAV) manufacturing remains a major bottleneck for gene therapy development.
Outpost Bio has raised $3.5 million in pre-seed funding to build frontier AI models that make human microbiology computable, enabling more precise prediction and optimization of intervention outcomes.
Firefinch Software has joined the Association of British HealthTech Industries (ABHI), aligning its specialist software capabilities with the UK’s leading healthtech network to better support health tech and medical device developers. This milestone coincides with Firefinch’s UK and Europe training roadshow, offering hands on support to teams building compliant software for medical devices.
22,000 sq ft of space in Wilton Centre’s Technical Development Area (TDA) has been leased to growing companies breathing new life into used metals and accelerating Teesside’s net zero ambitions.
It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.
In this guest blog, Hareklea Markides, Innovation Lead - Medicines Manufacturing at Innovate UK, reflects on the UK BioIndustry Association's (BIA) annual #bioProcessUK conference.
In this blog, Abby Clark, Manufacturing Programme Manager at BIA, highlights some of the key achievements of BIA and ABPI’s Medicines Manufacturing Industry Partnership (MMIP).
